Andera Partners

Venture capital firm

We track Andera Partners but have little verified detail yet.

Portfolio

1 total

Recent Investment Activity

1

Track record: led 1 and participated in 0 of 1 tracked venture round · 1 in the last 12 months · led 1 Growth

DateCompanyEventRoleAmountValuationInvestorsSource
Sep 22, 2026HighLifeGrowthLed$90M—Pulse story

Co-Investors

4

Latest Pulse

  1. HighLife Raises $90M For US Heart Valve StudyHighLife raised more than $90 million co-led by Andera Partners and Sofinnova Partners to fund a US pivotal study of its transcatheter mitral valve system and accelerate its European commercial rollout.→
  2. Cyllene Therapeutics Raises €33M for Gene TherapyCyllene Therapeutics, formerly EG 427, raised €33 million co-led by Merck Ventures to advance its HSV-1 gene-therapy platform toward treating neurogenic bladder conditions.→

Andera Partners FAQ

What companies has Andera Partners invested in?

Andera Partners' portfolio includes HighLife.

Who does Andera Partners co-invest with most?

In the rounds Value Add tracks, Andera Partners most often invests alongside European Investment Bank (1 shared deal), Sectoral Asset Management (1 shared deal), Sofinnova Partners (1 shared deal), Vi Partners (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction